Platforms
Creative Biolabs offers cutting-edge protein degraders platforms to accelerate your research, specializing in homo-protein degraders, ATTEC, and trivalent protein degraders. For homo-protein degraders, we provide end-to-end solutions, from design and optimization to in vitro/in vivo validation, leveraging homologous interaction mechanisms for precise target engagement. Our ATTEC platform focuses on autophagy-targeting small molecules, enabling degradation of intracellular aggregates via lysosomal pathways, with comprehensive screening and mechanistic studies. For Trivalent Protein Degraders, we develop multi-functional molecules that simultaneously bind target proteins, E3 ligases, and co-targets, enhancing specificity and efficacy through advanced combinatorial chemistry. Backed by our state-of-the-art facilities and expert team, we offer fully customizable workflows, from early-stage molecule design to preclinical evaluation, ensuring tailored strategies for your project.
Contact us now to explore our innovative protein degraders platforms and unlock personalized solutions for your research goals!
